Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q1 2016 · 10-Q
Revenue$471.20M$471.20M−0.3% vs Q1 2015 Net Income$11.00M$11.00M−38.2% vs Q1 2015 EPS Diluted$0.37$0.37−39.3% vs Q1 2015 Gross Profit$264,000,000−2.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flow-$7,448,000N/M Free Cash Flowderived-$32,744,000N/M Margins · derivedGross margin56.0%−1.1 pt vs Q1 2015
Operating margin4.3%−3.0 pt vs Q1 2015
Net margin2.3%−1.4 pt vs Q1 2015
ended Mar 31, 2016 · filed May 6, 2016 · 36 d after period end